Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT

Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT

The secretory leukocyte protease inhibitor (SLPI) is a serine protease inhibitor which plays important role in bacterial infection, inflammation, wound healing and epithelial proliferation. Dysregulation of SLPI has been reported in a variety of human cancers including glioblastoma, lung, breast, ov...

Full description

Bibliographic Details
Main Authors: Zhijiang Wei, Guiying Liu, Rufu Jia, Wei Zhang, Li Li, Yuanyuan Zhang, Zhijing Wang, Xiyong Bai
Format: Article
Language:English
Published: PeerJ Inc. 2020-07-01
Series:PeerJ
Subjects:
Secretory leukocyte protease inhibitor
Colorectal cancer
AKT
Online Access:https://peerj.com/articles/9400.pdf

Similar Items

Similar Items